Pang R - Search Results

1

Circulating microRNAs as specific biomarkers for breast cancer detection.

Ng EK, Li R, Shin VY, Jin HC, Leung CP, Ma ES, Pang R, Chua D, Chu KM, Law WL, Law SY, Poon RT, Kwong A. Ng EK, et al. Among authors: pang r. PLoS One. 2013;8(1):e53141. doi: 10.1371/journal.pone.0053141. Epub 2013 Jan 3. PLoS One. 2013. PMID: 23301032 Free PMC article.

2

PIN1 overexpression and beta-catenin gene mutations are distinct oncogenic events in human hepatocellular carcinoma.

Pang R, Yuen J, Yuen MF, Lai CL, Lee TK, Man K, Poon RT, Fan ST, Wong CM, Ng IO, Kwong YL, Tse E. Pang R, et al. Oncogene. 2004 May 20;23(23):4182-6. doi: 10.1038/sj.onc.1207493. Oncogene. 2004. PMID: 15064734

3

Molecular pathways in hepatocellular carcinoma.

Pang R, Tse E, Poon RT. Pang R, et al. Cancer Lett. 2006 Aug 28;240(2):157-69. doi: 10.1016/j.canlet.2005.08.031. Epub 2005 Oct 17. Cancer Lett. 2006. PMID: 16239065 Review.

4

Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma.

Pang R, Poon RT. Pang R, et al. Cancer Lett. 2006 Oct 28;242(2):151-67. doi: 10.1016/j.canlet.2006.01.008. Epub 2006 Mar 27. Cancer Lett. 2006. PMID: 16564617 Review.

5

Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.

Pang R, Lee TK, Poon RT, Fan ST, Wong KB, Kwong YL, Tse E. Pang R, et al. Gastroenterology. 2007 Mar;132(3):1088-103. doi: 10.1053/j.gastro.2006.12.030. Epub 2006 Dec 19. Gastroenterology. 2007. PMID: 17383430

6

High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.

Poon RT, Lau C, Pang R, Ng KK, Yuen J, Fan ST. Poon RT, et al. Among authors: pang r. Ann Surg Oncol. 2007 Jun;14(6):1835-45. doi: 10.1245/s10434-007-9366-z. Epub 2007 Apr 4. Ann Surg Oncol. 2007. PMID: 17406950

7

A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer.

Pang R, Law WL, Chu AC, Poon JT, Lam CS, Chow AK, Ng L, Cheung LW, Lan XR, Lan HY, Tan VP, Yau TC, Poon RT, Wong BC. Pang R, et al. Cell Stem Cell. 2010 Jun 4;6(6):603-15. doi: 10.1016/j.stem.2010.04.001. Cell Stem Cell. 2010. PMID: 20569697 Free article.

8

Phase 1-2 trial of PTK787/ZK222584 combined with intravenous doxorubicin for treatment of patients with advanced hepatocellular carcinoma: implication for antiangiogenic approach to hepatocellular carcinoma.

Yau T, Chan P, Pang R, Ng K, Fan ST, Poon RT. Yau T, et al. Among authors: pang r. Cancer. 2010 Nov 1;116(21):5022-9. doi: 10.1002/cncr.25372. Cancer. 2010. PMID: 20629034 Free article. Clinical Trial.

9

Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib.

Yau T, Pang R, Chan P, Poon RT. Yau T, et al. Among authors: pang r. Expert Opin Pharmacother. 2010 Sep;11(13):2187-98. doi: 10.1517/14656561003724705. Expert Opin Pharmacother. 2010. PMID: 20707757 Review.

10

The significance of early alpha-fetoprotein level changes in predicting clinical and survival benefits in advanced hepatocellular carcinoma patients receiving sorafenib.

Yau T, Yao TJ, Chan P, Wong H, Pang R, Fan ST, Poon RT. Yau T, et al. Among authors: pang r. Oncologist. 2011;16(9):1270-9. doi: 10.1634/theoncologist.2011-0105. Epub 2011 Sep 1. Oncologist. 2011. PMID: 21885876 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

983 results

Search Page

Filters